Lee Sonin
Allergy · Schaumburg, ILNPI 1376571497
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 376 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 23 manufacturers, the largest accounting for just 17.7% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $2,335 and has fallen 98.1% since, to $45 in 2023.
Across 376 payments — averaging $19.68 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$1K
- GSK$1K
- CSL Behring$1K
- Regeneron Healthcare Solutions, Inc.$683
- Optinose US, Inc.$593
- Biocryst US Sales Co., LLC$408
- plus $2K from 17 others
What the payments were for
- Food & beverage$7,397100%
- Education$10%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 59 | $1,311 |
| GSK | 76 | $1,112 |
| CSL Behring | 55 | $1,095 |
| Regeneron Healthcare Solutions, Inc. | 22 | $683 |
| Optinose US, Inc. | 39 | $593 |
| Biocryst US Sales Co., LLC | 23 | $408 |
| Covis Pharma GmbH | 16 | $345 |
| Genentech USA, Inc. | 13 | $265 |
| Boehringer Ingelheim | 12 | $256 |
| Takeda Pharmaceuticals U.S.A., Inc. | 10 | $229 |
| Shire North American Group Inc | 8 | $184 |
| Pharming Healthcare, Inc. | 8 | $172 |
| Pfizer | 8 | $150 |
| Amgen | 3 | $130 |
| Teva Pharmaceuticals USA, Inc. | 5 | $114 |
| Kaleo, Inc. | 4 | $78 |
| Sanofi | 3 | $61 |
| Novartis | 3 | $55 |
| Biocryst Pharmaceuticals, Inc. | 2 | $45 |
| Aimmune Therapeutics, Inc. | 2 | $34 |
| Merck | 2 | $28 |
| Alk-abello, Inc | 2 | $27 |
| USWM, LLC | 1 | $25 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- FASENRA$233
How this compares
$7,398 in reported general payments places this provider in the 80th percentile of 47 allergy providers in Illinois.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Montelukast Sodium | 12 | $119 |
Paid to pharmacies, not to this prescriber.
Other allergy in Schaumburg
- Ewa SchaferGlenview$165K
- Brian RotskoffChicago$82K
- Bruce BochnerChicago$43K
- Mark MillerHoffman Estates$17K
- Mohammad GhaniWestchester$16K
- Sai NimmagaddaOrland Park$14K
- Archana NarayanJoliet$11K
- Alan ResnickOrland Park$9K
- Alex ThomasChicago$9K
- Renu GovindaiahSpringfield$7K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.